eXoZymes (Invizyne)

eXoZymes Inc., formerly known as Invizyne Technologies, is a biotechnology company that specializes in next-generation biomanufacturing. The company has developed a proprietary platform that utilizes AI-engineered enzymes to perform chemical transformations in a cell-free bioreactor environment. By liberating enzymes from the limitations of working within living cells, this technology allows for the controlled and optimized production of chemical compounds that were previously difficult or impossible to scale. The core innovation, described as Exozymes, provides a foundation for high-purity natural product synthesis.

The company’s biomanufacturing solutions are designed to replace traditional, often toxic or inefficient, petrochemical production methods with sustainable and eco-friendly alternatives. By transforming affordable and widely available feedstocks, eXoZymes aims to produce a diverse range of high-value small-molecule chemicals, including active pharmaceutical ingredients (APIs), nutraceuticals, and biofuels. This technology provides partners in the pharmaceutical and chemical industries with a scalable, predictable way to manufacture complex molecules, helping to address challenges in production efficiency and environmental impact. Based in Monrovia, California, and publicly traded on the NASDAQ under the ticker EXOZ, the company continues to advance its platform to address global demands for sustainable chemical manufacturing.